Does VINORELBINE Cause Tumour marker increased? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Tumour marker increased have been filed in association with VINORELBINE (Vinorelbine). This represents 0.4% of all adverse event reports for VINORELBINE.
18
Reports of Tumour marker increased with VINORELBINE
0.4%
of all VINORELBINE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Tumour marker increased From VINORELBINE?
Of the 18 reports, 2 (11.1%) required hospitalization, and 1 (5.6%) were considered life-threatening.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINORELBINE. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does VINORELBINE Cause?
Off label use (644)
Malignant neoplasm progression (624)
Disease progression (526)
Neutropenia (517)
Nausea (504)
Drug ineffective (391)
Fatigue (373)
Diarrhoea (371)
Vomiting (342)
Anaemia (335)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which VINORELBINE Alternatives Have Lower Tumour marker increased Risk?
VINORELBINE vs VINORELBINE\VINORELBINE
VINORELBINE vs VIREAD
VINORELBINE vs VISIPAQUE
VINORELBINE vs VISMODEGIB
VINORELBINE vs VITAMIN A